tiprankstipranks
Advertisement
Advertisement
Beacon Therapeutics Executive to Join Advanced Therapies U.K. 2026 Gene Therapy Panel
PremiumPrivate CompaniesBeacon Therapeutics Executive to Join Advanced Therapies U.K. 2026 Gene Therapy Panel
25d ago
Beacon Therapeutics Highlights Gene Therapy Expertise at Advanced Therapies UK 2026
Premium
Private Companies
Beacon Therapeutics Highlights Gene Therapy Expertise at Advanced Therapies UK 2026
25d ago
Beacon Therapeutics Emphasizes Retinal Gene Therapy Focus at Investing in Cures Summit
Premium
Private Companies
Beacon Therapeutics Emphasizes Retinal Gene Therapy Focus at Investing in Cures Summit
28d ago
Beacon Therapeutics Emphasizes Lead Gene Therapy Program in XLRP
PremiumPrivate CompaniesBeacon Therapeutics Emphasizes Lead Gene Therapy Program in XLRP
1M ago
Beacon Therapeutics Highlights Phase 2 DAWN Trial Data Presentation for XLRP Gene Therapy
Premium
Private Companies
Beacon Therapeutics Highlights Phase 2 DAWN Trial Data Presentation for XLRP Gene Therapy
1M ago
Beacon Therapeutics Highlights Phase 2 DAWN Trial Data for XLRP Gene Therapy
Premium
Private Companies
Beacon Therapeutics Highlights Phase 2 DAWN Trial Data for XLRP Gene Therapy
1M ago
Beacon Therapeutics Highlights $75M Series C to Advance Gene Therapy Pipeline
PremiumPrivate CompaniesBeacon Therapeutics Highlights $75M Series C to Advance Gene Therapy Pipeline
1M ago
Beacon Therapeutics Highlights Oversubscribed Series C and XLRP Trial Progress
Premium
Private Companies
Beacon Therapeutics Highlights Oversubscribed Series C and XLRP Trial Progress
2M ago
Beacon Therapeutics Highlights Series C Financing and Clinical Progress in XLRP Program
Premium
Private Companies
Beacon Therapeutics Highlights Series C Financing and Clinical Progress in XLRP Program
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100